Literature DB >> 10219069

Chronic myeloid leukemia.

C L Sawyers1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219069     DOI: 10.1056/NEJM199904293401706

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  313 in total

1.  A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.

Authors:  D Barilá; R Mangano; S Gonfloni; J Kretzschmar; M Moro; D Bohmann; G Superti-Furga
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

Review 2.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 3.  Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive Ras.

Authors:  Anica Wandler; Kevin Shannon
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

4.  Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia.

Authors:  Dana Paquin; Peter S Kim; Peter P Lee; Doron Levy
Journal:  Bull Math Biol       Date:  2010-06-09       Impact factor: 1.758

5.  Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment.

Authors:  Su Chu; Tinisha McDonald; Allen Lin; Sujata Chakraborty; Qin Huang; David S Snyder; Ravi Bhatia
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

6.  Successful treatment with imatinib mesylate of a CML patient in megakaryoblastic crisis with severe fibrosis.

Authors:  Yuka Hirose; Hitoshi Kiyoi; Masanori Iwai; Toshiya Yokozawa; Masafumi Ito; Tomoki Naoe
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

7.  Disruption of Survivin in K562 cells elevates telomerase activity and protects cells against apoptosis induced by the Bcr-abl kinase inhibitor STI571.

Authors:  Zhanxiang Wang; Louis M Pelus
Journal:  Cancer Ther       Date:  2008

8.  Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia?

Authors:  J Björk; M Albin; H Welinder; H Tinnerberg; N Mauritzson; T Kauppinen; U Strömberg; B Johansson; R Billström; Z Mikoczy; T Ahlgren; P G Nilsson; F Mitelman; L Hagmar
Journal:  Occup Environ Med       Date:  2001-11       Impact factor: 4.402

Review 9.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

Review 10.  FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.

Authors:  Zainab Jagani; Amrik Singh; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2007-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.